|1.||Miller, T J: 1 article (12/2011)|
|2.||Grappin, L: 1 article (03/2011)|
|3.||Hurtgen, C: 1 article (03/2011)|
|4.||Fritsch, P: 1 article (03/2011)|
|5.||Grémy, O: 1 article (03/2011)|
|6.||Poncy, J L: 1 article (03/2011)|
|7.||Bérard, P: 1 article (03/2011)|
|8.||Sambrano, Julio R: 1 article (09/2008)|
|9.||Angelotti, Wagner F D: 1 article (09/2008)|
|10.||de Macedo, Luiz Guilherme M: 1 article (09/2008)|
|1.||Sarcoma (Soft Tissue Sarcoma)
|2.||Wounds and Injuries (Trauma)
12/01/2011 - "Sensitivities of around 1 µSv, for fission and activation products in the whole body and around 1 mSv, for actinides in wounds, were achieved using single large collimated, but otherwise unshielded, detectors."
11/01/1997 - "Consequently, it is important that lung monitoring programs for occupational workers handling actinides are conducted with this caution in mind and that due consideration is given even in cases of minor cuts/wounds in order to rule out substantial overestimation of internal radiation doses."
07/01/1993 - "This was attributed to the greater retention of these actinides at the wound site (97 versus 67%) when treatment commenced. "
11/01/2006 - "In case of accidental release of radionuclides into the environment, actinides represent a severe health risk to human beings following internal contamination (inhalation, ingestion or wound). "
03/01/2011 - "Abstract models have been developed to describe dissolution of Pu/Am/Cm after internal contamination by inhalation or wound, chelation of actinides by diethylene triamine penta acetic acid (DTPA) in different retention compartments and excretion of actinide-DTPA complexes. "
|3.||Osteosarcoma (Osteogenic Sarcoma)
10/01/1995 - "Deposits of actinides in bone should be minimized because development of osteosarcoma appears to be related to internal exposure. "
03/01/1993 - "Deposition of actinides in bone must be minimized because osteosarcoma appears to be the most likely pathological effect arising from systemic exposure. "
|4.||Bone Fractures (Bone Fracture)
01/01/1997 - "These include skeletal deposition of radium and radiostrontium in bone volume; deposition on bone surfaces of plutonium and other actinides; liver deposition of actinides; induction of skeletal or liver malignancies by these radionuclides; induction of tooth and jaw abnormalities; mammary cancer induction by radium in humans and in the beagle; depression of circulating cells in blood; and induction of bone fractures. "
|2.||Pentetic Acid (DTPA)
|3.||Acetic Acid (Vinegar)